Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$4.11 - $7.63
Next Earnings Date
May 14 2025
Next Earnings Date
May 14 2025
Latest price
Market Cap | $1.40B |
EV | $1.35B |
Shares Outstanding | 307.78M |
Beta | 1.21 |
Analyst Rating | BUY |
Analyst Target Price | $10.29 |
P/E 2025E | 26.09x |
P/Revenue 2025E | 4.41x |
Revenue | 55.80% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 12.00% |
EPS | 47.40% |
Operating Cash Flow | 47.70% |
Free Cash Flow | 65.90% |
Gross Margin 2025E | 75.40% |
Net Profit Margin 2025E | 16.90% |
ROE 2025E | - |
ROCE 2024 | - |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
MannKind Corporation
MNKD
Sector
Healthcare
Industry
Biotechnology
CEO
Castagna, Michael
Employees
405
Website
www.mannkindcorp.comIPO Date
2004-07-28
Headquarters
1 Casper Street, Danbury, Connecticut, 06810, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved